KR890004688A - 생활성 물질의 조절성 방출성을 위한 피복 제재 - Google Patents

생활성 물질의 조절성 방출성을 위한 피복 제재 Download PDF

Info

Publication number
KR890004688A
KR890004688A KR1019880011435A KR880011435A KR890004688A KR 890004688 A KR890004688 A KR 890004688A KR 1019880011435 A KR1019880011435 A KR 1019880011435A KR 880011435 A KR880011435 A KR 880011435A KR 890004688 A KR890004688 A KR 890004688A
Authority
KR
South Korea
Prior art keywords
coating
composition
cellulose
polymer
pattern
Prior art date
Application number
KR1019880011435A
Other languages
English (en)
Other versions
KR910002075B1 (ko
Inventor
에스 암베고안칼 아닐
알란 호웰스 로저
Original Assignee
워리암 에프. 마쉬
에어프로덕츠 앤드 캐미칼스 인코오포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 워리암 에프. 마쉬, 에어프로덕츠 앤드 캐미칼스 인코오포레이티드 filed Critical 워리암 에프. 마쉬
Publication of KR890004688A publication Critical patent/KR890004688A/ko
Application granted granted Critical
Publication of KR910002075B1 publication Critical patent/KR910002075B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

생활성 물질의 조절성 방출을 위한 피복 제재
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 이중 피복의 조절성 및 보존성 방출을 위한 생활성 물질 조성물의 다이아그램이다.
제2도는 실시예1에 개시된 방법에 따라 산출된 조절 방출성 레오필렌에 대한 용해 방출 프로필을 도시한 것이다.
제3도는 실시예 2에 개시된 방법에 따라 산출된 조절 방출성 레오필렌에 대한 용해 방출 프로필을 표시한 것이다.

Claims (6)

  1. 하기 (a),(b)및 (c)로 구성됨으로써 조성물이 적합한 주위 매체에 노출될 때 생활성 물질의 조절 방출을 유발하는 적합한 주위 매체와의 접촉시 조절성의 보존 방출 운반 패턴을 갖는 생활성 조성물, (a) 특정 치료 기간전 투약중 적어도 충분한 양으로 존재하는 주위 매체에 용해되는 약학적, 살충적, 제초적 혹은 비료성의 생활성 물질의 코어, (b) 주위 매체에 의해 침투되자 마자 팽창될 수 있는 중합체 또는 중합체 혼합물로 구성되는 생활성 물질 코어를 둘러싸는 제1피복 및, (c) 물-불용성이며, 주위 매체에 용해된 생활성 물질의 외향 확산 및 주위 매체의 내향 확산을 방지하는 반-투과 배리어를 형성하는 중합체 또는 중합체 혼합물로 구성되는 제1피복을 둘러싸는 제2피복.
  2. 제1항에 있어서, 제1피복은 또한 가소제를 포함하는 것을 특징으로 하는 조성물.
  3. 제1항에 있어서, 조절성의 보존 방출 운반 패턴은 재로-오미 패턴이고, 제2피복은 제1피복을 통해 침투제의 확산이 속도조절 단계가 되도록 유발하는 효과적인 투과성 및 효과적 두께로 존재하고, 제2피복은 제1피복의 팽창으로 인한 제2피복의 파쇄를 방지할 수 있도록 신축성을 갖는 것을 특징으로 하는 조성물.
  4. 제1항에 있어서, 조절성의 보존 방출 운반 패턴은 이중상 패턴이고, 제2피복은 제1피복을 통한 침투제의 확산이 속도조절 단계가 되도록 효과적인 투과성 및 효과적 두께로 존재하고, 제2피복은 방출패턴에서 특정 시간동안 제1피복의 팽창으로 인해 제2피복의 파쇄를 방지할 수 있도록 신축성을 갖는 것을 특징으로 하는 조성물.
  5. 제1항에 있어서, 제1피복 중합체 또는 중합체들의 혼합물은 히드록시프로필 셀룰 로오스, 히드록시프로필 메틸 셀룰로오스, 폴리비닐 알콜, 폴리비닐 피롤리돈 및 이것들의 혼합물로 구성되는 그룹으로부터 선택되는 것을 특징으로 하는 조성물.
  6. 제1항에 있어서, 제 2피복 중합체 또는 중합체들의 혼합물은 에틸 셀룰로오스, 에틸 셀룰로오스 및 히드록시프로필 셀룰로오스, 에틸 셀룰로오스 및 메틸 셀룰로오스, 에틸 셀룰로오스 및 히드록시 셀룰로오스, 히드록시프로필 메틸 셀룰로오스 및 로진으로 구성되는 그룹으로부터 선택되는 것을 특징으로 하는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880011435A 1987-09-03 1988-09-03 생활성 물질의 조절 방출성 피복제제 KR910002075B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US092743 1987-09-03
US07/092,743 US4891223A (en) 1987-09-03 1987-09-03 Controlled release delivery coating formulation for bioactive substances
US92743 2005-03-30

Publications (2)

Publication Number Publication Date
KR890004688A true KR890004688A (ko) 1989-05-09
KR910002075B1 KR910002075B1 (ko) 1991-04-03

Family

ID=22234898

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880011435A KR910002075B1 (ko) 1987-09-03 1988-09-03 생활성 물질의 조절 방출성 피복제제

Country Status (10)

Country Link
US (1) US4891223A (ko)
EP (1) EP0305918B1 (ko)
JP (1) JPH0825870B2 (ko)
KR (1) KR910002075B1 (ko)
CA (1) CA1330942C (ko)
DE (1) DE3876724T2 (ko)
DK (1) DK175383B1 (ko)
ES (1) ES2052656T3 (ko)
NO (1) NO178486C (ko)
ZA (1) ZA886551B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59000232D1 (de) * 1989-02-11 1992-09-10 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5707637A (en) * 1990-12-14 1998-01-13 American Cyanamid Company Granulated soil insecticidal-nematicidal compositions with reduced mammalian dermal toxicity
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5652196A (en) * 1991-07-22 1997-07-29 Oms Investments, Inc. Timed release of water-soluble plant nutrients
US5335449A (en) * 1991-08-15 1994-08-09 Net/Tech International, Inc. Delivery system for an agriculturally active chemical
US5526607A (en) * 1991-08-15 1996-06-18 Net/Tech International Water dispersible delivery system for an agriculturally active chemical
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
FR2692754B1 (fr) * 1992-06-26 1995-06-30 Ube Industries Compositions chimiques pour l'agriculture, en granules a double enrobage.
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
ES2157915T3 (es) * 1993-06-07 2001-09-01 Oms Investments Inc Liberacion prolongada de sustancias solubles en agua nutritivas para vegetales.
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5698002A (en) * 1994-11-21 1997-12-16 Lesco Inc. Controlled release fertilizers utilizing an epoxy polymer primer coat and methods of production
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US6039975A (en) * 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US20060068001A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
AU726550B2 (en) * 1997-01-20 2000-11-09 Jnc Corporation Timed-release control-type coated granular pesticide
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6511477B2 (en) * 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
IL135502A (en) * 1997-10-09 2006-07-05 Dexcel Pharma Technologies Ltd A system that completely suspends the release of a drug in the gastrointestinal tract
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
AU1534699A (en) * 1997-12-05 1999-06-28 Alza Corporation Osmotic dosage form comprising first and second coats
GR1003326B (el) * 1998-01-15 2000-03-03 Μεθοδος παραγωγης συστηματων εγκλωβισμου βιολογικα ελεγχομενης αποδοσης
DE19820529A1 (de) 1998-05-08 1999-11-11 Lohmann Therapie Syst Lts Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
CN100391438C (zh) * 1999-09-14 2008-06-04 史密丝克莱恩比彻姆公司 制备水性包被小球粒的方法
CA2395974A1 (en) * 2000-01-20 2001-07-26 Suggy S. Chrai Multi-step drug dosage forms
JP2003521507A (ja) 2000-02-04 2003-07-15 ディポメド，インコーポレイティド ゼロ次薬物放出に接近するシェル−コア剤形
US6761895B2 (en) * 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6444316B1 (en) 2000-05-05 2002-09-03 Halliburton Energy Services, Inc. Encapsulated chemicals for use in controlled time release applications and methods
US20030157247A1 (en) * 2000-06-14 2003-08-21 Yoshiro Chikami Method for producing coated bioactive granule
CA2423484A1 (en) 2000-09-27 2002-04-04 Verion Inc. Instant water dissolvable encapsulate and process
US7964216B2 (en) * 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
JP5005157B2 (ja) 2001-03-13 2012-08-22 ペンウェスト ファーマシューティカルズ カンパニー 時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
KR200249057Y1 (ko) * 2001-03-22 2001-10-19 김진환 뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
ES2373873T3 (es) * 2001-04-10 2012-02-09 Sun Pharma Advanced Research Company Limited Composición de liberación por impulso temporizado.
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
CA2470636A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
EP1482910A1 (en) * 2002-03-05 2004-12-08 Ranbaxy Laboratories, Ltd. Modified release oral pharmaceutical composition
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) * 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) * 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
WO2005027878A1 (en) 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Delayed released dosage forms
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060204613A1 (en) * 2005-02-18 2006-09-14 Castro Armando J Chewing gum containing flavor delivery systems
US20060286200A1 (en) * 2005-04-18 2006-12-21 Castro Armando J Confections containing flavor delivery systems
US7905287B2 (en) 2005-04-19 2011-03-15 Halliburton Energy Services Inc. Methods of using a polymeric precipitate to reduce the loss of fluid to a subterranean formation
US7943555B2 (en) * 2005-04-19 2011-05-17 Halliburton Energy Services Inc. Wellbore treatment kits for forming a polymeric precipitate to reduce the loss of fluid to a subterranean formation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
JP2006327943A (ja) * 2005-05-23 2006-12-07 Towa Yakuhin Kk 経時的溶出遅延を抑制したテイストマスク錠剤
US8455404B2 (en) * 2005-07-15 2013-06-04 Halliburton Energy Services, Inc. Treatment fluids with improved shale inhibition and methods of use in subterranean operations
US7833945B2 (en) * 2005-07-15 2010-11-16 Halliburton Energy Services Inc. Treatment fluids with improved shale inhibition and methods of use in subterranean operations
US20070072775A1 (en) * 2005-09-29 2007-03-29 Oms Investments, Inc. Granular controlled release agrochemical compositions and process for the preparation thereof
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US8124598B2 (en) * 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
MX2011001384A (es) 2008-08-06 2011-09-27 Gosforth Ct Holdings Pty Ltd Composiciones y metodos para tratar trastornos psiquiatricos.
AU2010211985A1 (en) * 2009-01-22 2011-08-11 Abbott Healthcare Private Limited Chronotherapeutic pharmaceutical composition
MX2011011506A (es) * 2009-04-28 2012-05-08 Proteus Biomedical Inc Marcadores de eventos ingeribles altamente confiables y metodos para utilizar los mismos.
AR076835A1 (es) * 2009-05-01 2011-07-13 Eurand Inc Composiciones de comprimidos de desintegracion oral que comprenden combinaciones de drogas en dosis elevadas y reducidas. metodo.
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CA2785468A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
KR20150144752A (ko) * 2013-03-15 2015-12-28 아다마 마켓심 리미티드 토양 중의 비료 및 다른 농화학물질의 효율적 흡수를 위한 인공 환경
WO2014144738A1 (en) 2013-03-15 2014-09-18 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US20150133516A1 (en) 2013-11-13 2015-05-14 Brian K. Adams Methods and Compositions for Treating ADHD
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
AU2016288643A1 (en) 2015-07-02 2018-02-22 University Of Louisville Research Foundation, Inc. Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN111493872B (zh) 2016-07-22 2023-05-05 大冢制药株式会社 可摄入事件标记的电磁感测和检测
US10820831B2 (en) 2016-10-26 2020-11-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4177056A (en) * 1974-06-27 1979-12-04 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers used as carriers for medicaments and pesticides
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4423099A (en) * 1980-07-28 1983-12-27 Ciba-Geigy Corporation Membrane modified hydrogels
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS58501128A (ja) * 1981-07-15 1983-07-14 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 徐放性テオフイリン
AU571312B2 (en) * 1984-02-10 1988-04-14 Nycomed Danmark A/S Diffusion coated multiple-units dosage form
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법

Also Published As

Publication number Publication date
EP0305918B1 (en) 1992-12-16
NO883918L (no) 1989-03-06
EP0305918A1 (en) 1989-03-08
DE3876724D1 (de) 1993-01-28
US4891223A (en) 1990-01-02
KR910002075B1 (ko) 1991-04-03
JPH0269414A (ja) 1990-03-08
NO178486C (no) 1996-04-10
ZA886551B (en) 1990-05-30
NO178486B (no) 1996-01-02
DK490788D0 (da) 1988-09-02
NO883918D0 (no) 1988-09-02
CA1330942C (en) 1994-07-26
DK490788A (da) 1989-03-04
ES2052656T3 (es) 1994-07-16
DE3876724T2 (de) 1993-05-27
JPH0825870B2 (ja) 1996-03-13
DK175383B1 (da) 2004-09-20

Similar Documents

Publication Publication Date Title
KR890004688A (ko) 생활성 물질의 조절성 방출성을 위한 피복 제재
DK0436370T3 (da) Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
KR870002832A (ko) 제약 조성물
DE59607490D1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
ATE96678T1 (de) Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
IE882898L (en) Solubility modulated drug delivery device
KR840009035A (ko) 피부 침투 치료 시스템용 매트릭스 조성물
BR9508620A (pt) Liberação de substâncias quimicas exógenas para tecidos de plantas
KR860002271A (ko) 조절되게 방출되게끔(controlled-release) 코오팅된 조제학상의 제제와 그 제제의 제조방법
ES2094815T3 (es) Composicion terapeutica y proceso para su preparacion.
PT739199E (pt) Adesivo de estradiol com agente reforcador da penetracao
ATE106719T1 (de) Arzneimittel mit gesteuerter wirkstoffreisetzung.
ATE267007T1 (de) Pharmazeutische tablette geeignet zur wirkstofffreisetzung in aufeinanderfolgenden und vorherbestimmbaren zeiträumen
DK0697858T3 (da) Nasalt medikamentafgivelsessystem indeholdende nikotin
SE8803321L (sv) Foerdroejd och styrd frigoering av vattenoloesliga polypeptider
NO171004C (no) Fremgangsmaate for fremstilling av en utleveringsanordningsom i naervaer av en opploesningsvaeske frigir en biologisk aktiv bestanddel ved en i praksis konstant hastighet under en utvidet tidsperiode
ATE244004T1 (de) Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung
EP0251464A3 (en) Composition for the control of insects
ES2144650T3 (es) Composicion emulsionable para la represion de insectos.
FR2671086B1 (fr) Peptides opiouides, leur procede de preparation, et composition pharmaceutique contenant ces peptides.
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE3883695D1 (de) Amid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Fungizide in der Agrikultur und im Gartenbau.
ATE250942T1 (de) Zusammensetzungen zur zersetzung von wasserstoffperoxid und verfahren zu deren verwendung
ES513422A0 (es) Procedimiento para la obtencion de un preparado medicamentoso de accion retardada que contiene un polimero hidrofilo de celulosa

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040331

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee